-
Zelluna Reaches Major Milestone with Manufacturing Process Established in Preparation for Clinical Entry of ZI-MA4-1, its Novel TCR-NK Therapy Targeting Solid Tumours
-
Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider
-
Zelluna ASA [ZLNA]: Notice of Annual General Meeting on April 29, 2025
-
Zelluna ASA [ZLNA]: Annual Report 2024
-
Zelluna ASA [ZLNA]: Ex reverse share split today
-
Zelluna ASA [ZLNA]: Registration of reverse share split
-
Zelluna ASA [ZLNA]: Key information regarding reverse share split and change of ISIN
-
Zelluna ASA [ZLNA]: Share capital increase registered
-
Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider
-
Zelluna ASA [ZLNA]: Share capital increase resolution
